Skip to content
healthcare.dev

STEGLUJAN

NDC 0006-5367, ertugliflozin and sitagliptin, tablet, film coated, from Merck Sharp & Dohme LLC.

Product NDC
0006-5367
Status
Listed
Labeler
Merck Sharp & Dohme LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA209805
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0006-5367 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERTUGLIFLOZIN PIDOLATE5 mg/1
  • SITAGLIPTIN PHOSPHATE100 mg/1

Pharmacologic classes

Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
0006-5367-030000653670330 TABLET, FILM COATED in 1 BOTTLE (0006-5367-03)
0006-5367-060000653670690 TABLET, FILM COATED in 1 BOTTLE (0006-5367-06)
0006-5367-0700006536707500 TABLET, FILM COATED in 1 BOTTLE (0006-5367-07)
0006-5367-09000065367092 BOTTLE in 1 CARTON (0006-5367-09) / 7 TABLET, FILM COATED in 1 BOTTLE (0006-5367-08)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c2c553d8-5a9d-4366-bf53-8bdb5a876d19

Use it

Look up 0006-5367 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0006-5367 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0006-5367. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.